REGENT PACIFIC (00575) announced its annual results, with a net loss of $4.71 million, an increase of 5.09% year-on-year.

Regent Pacific (00575) announced its annual performance for the year ending December 31, 2025. The group achieved a revenue of $363,000, a 49.51% decrease compared to the previous year. The company incurred a loss of $4.71 million, a 5.09% increase compared to the previous year. The loss per share was 1.8 cents. In 2025, the company continued to solidify its position as a commercial-stage biopharmaceutical company, making steady progress in business execution. The company is advancing its vision of granting its drug rights to large pharmaceutical companies for royalty fees and milestone payments, while also focusing on becoming a leader in the longevity journey by providing cutting-edge, AI-driven anti-aging solutions.